HealthQuill Health
Bavarian Nordic gets FDA nod for free-dried smallpox, mpox vaccine.
Drugs Health Pharma

Bavarian Nordic gets FDA nod for free-dried smallpox, mpox vaccine

HQ Team April 2, 2025: Denmark’s Bavarian Nordic A/S has got approval from the US Food and Drug Administration for its freeze-dried formulation.

Read More
Sudan’s humanitarian crisis and security situation remain “dire and worsening,” with a famine looming on the horizon, according to a UN official.
Drugs Health Medical

Sudan heading for famine as fighting ravages Darfur, UN warns

HQ Team April 2, 2025: Sudan’s humanitarian crisis and security situation remain “dire and worsening,” with a famine looming on the horizon, according.

Read More
Aardvark Weather, an artificial intelligence weather predicting system, can deliver accurate forecasts tens of times faster and using thousands of times less computing power than current AI and physics-based forecasting systems, according to researchers.
Climate Health Research

New AI-driven weather system to deliver forecasts ten times faster

HQ Team April 1, 2025: Aardvark Weather, an artificial intelligence weather predicting system, can deliver accurate forecasts tens of times faster and using.

Read More
Three-hundred and twenty-nine people died after being infected with cholera in the West African nation of Angola as the disease spread to 16 of the country’s 21 provinces, according to the World Health Organization.
Climate Drugs Health

Cholera claims lives of 329 people in Angola, WHO says spread risk is ‘high’

HQ Team April 1, 2025: Three-hundred and twenty-nine people died after being infected with cholera in the West African nation of Angola as.

Read More
AstraZeneca’s drug to treat adult patients with previously untreated mantle cell lymphoma has been recommended for European Union approval.
Drugs Health Pharma

AstraZeneca’s mantle cell cancer drug gets body’s nod for EU approval

HQ Team April 1, 2025: AstraZeneca’s drug to treat adult patients with previously untreated mantle cell lymphoma has been recommended for European Union.

Read More
One to five years of antidepressant usage, increases the risk of sudden cardiac death by 56%, according to a Danish study, which found that the risk more than doubles in those using for six years and above.
Drugs Health Research

Antidepressant use for upto 5 years ups sudden cardiac death by 56%

HQ Team April 1, 2025: One to five years of antidepressant usage, increases the risk of sudden cardiac death by 56%, according to.

Read More
The Cystic Fibrosis Foundation will invest up to $2.3 million in Owlstone Medical to develop a test that is designed to detect Pseudomonas infections from a person’s breath.
Drugs Health Medical

CF Foundation to fund project to find lung infections from people’s breath

HQ Team March 26, 2025: The Cystic Fibrosis Foundation will invest up to $2.3 million in Owlstone Medical to develop a test that.

Read More
The World Health Organization has issued new guidelines to help reform and strengthen mental health policies and systems at a time when up to 90% of the people in some nations with severe mental health conditions receive no care at all.
Health Medical Pharma

WHO unveils new guidelines to tackle mental health systems, policies

HQ Team March 26, 2025: The World Health Organization has issued new guidelines to help reform and strengthen mental health policies and systems.

Read More
At least 2,515 people were killed along the perilous migration routes in Asia last year, making it the deadliest on record, according to the UN International Organization for Migration.
Climate Drugs Health

Asia migration deaths highest in the world at 2,515 people: IOM 

HQ Team Wednesday 26, 2025: At least 2,515 people were killed along the perilous migration routes in Asia last year, making it the.

Read More
Merck & Co., Inc. has bought global rights for an experimental oral drug to treat heart diseases from China’s Jiangsu Hengrui Pharmaceuticals Co., Ltd. in a $2 billion deal.
Drugs Health Pharma

Merck signs $2b licensing deal with Jiangsu Hengrui for heart disease drug

HQ Team March 25, 2025: Merck & Co., Inc. has bought global rights for an experimental oral drug to treat heart diseases from.

Read More